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Prefrontal cortexPerineuronal nets (PNNs) were shown to be markedly altered in subjects with schizophrenia. In particular,
decreases of PNNs have been detected in the amygdala, entorhinal cortex and prefrontal cortex. The formation
of these specialized extracellularmatrix (ECM) aggregates during postnatal development, their functions, and as-
sociation with distinct populations of GABAergic interneurons, bear great relevance to the pathophysiology of
schizophrenia. PNNs gradually mature in an experience-dependent manner during late stages of postnatal
development, overlapping with the prodromal period/age of onset of schizophrenia. Throughout adulthood,
PNNs regulate neuronal properties, including synaptic remodeling, cell membrane compartmentalization and
subsequent regulation of glutamate receptors and calcium channels, and susceptibility to oxidative stress.
With the present paper, we discuss evidence for PNN abnormalities in schizophrenia, the potential functional
impact of such abnormalities on inhibitory circuits and, in turn, cognitive and emotion processing. We integrate
these considerations with results from recent genetic studies showing genetic susceptibility for schizophrenia
associated with genes encoding for PNN components, matrix-regulating molecules and immune system factors.
Notably, the composition of PNNs is regulated dynamically in response to factors such as fear, reward, stress,
and immune response. This regulation occurs through families of matrix metalloproteinases that cleave ECM
components, altering their functions and affecting plasticity. Several metalloproteinases have been proposed as
vulnerability factors for schizophrenia. We speculate that the physiological process of PNN remodeling may be
disrupted in schizophrenia as a result of interactions betweenmatrix remodeling processes and immune system
dysregulation. In turn, these mechanisms may contribute to the dysfunction of GABAergic neurons.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. IntroductionPerineuronal nets (PNNs), ﬁrst described by “Camillo Golgi” (1898),
are specialized aggregates of extracellular matrix (ECM) molecules sur-
rounding the somata, dendrites and proximal axon segment of distinct
neuronal populations (Fig. 1) (Golgi, 1898; Brauer et al., 1993; Seeger
et al., 1994; Celio et al., 1998; Vitellaro-Zuccarello et al., 1998; Spreaﬁco
et al., 1999; Kwok et al., 2011). Longbelieved to be responsible primarily
for structural support, PNNs have in recent years come to the forefront
of neuroscience research as critical elements regulating synaptic func-
tions and plasticity during development and adulthood (Pizzorusso
et al., 2002; Gogolla et al., 2009; Dityatev et al., 2010; Gundelﬁnger
et al., 2010; Beurdeley et al., 2012; Yamada and Jinno, 2013; Xue et al.,
2014). Emerging evidence from human postmortem studies highlights
the involvement of PNNs in schizophrenia (SZ) (Pantazopoulos et al.,
2010; Mauney et al., 2013; Pantazopolous et al., 2014). The relevance149, 115 Mill St., Belmont, MA
retta).
. This is an open access article underof PNN abnormalities to GABAergic neuron dysfunction in SZ is the
main topic of this manuscript. We focus predominantly on evidence
based on chondroitin sulfate proteoglycans (CSPGs), one of their main
PNN components (Deepa et al., 2006; Carulli et al., 2007; Giamanco
and Matthews, 2012). Importantly, other PNN elements, namely Reelin
and semaphorin 3A, have been shown to be involved in the pathophys-
iology of SZ, although not directly as PNN components (Impagnatiello
et al., 1998; Costa et al., 2001; Eastwood et al., 2003; Abdolmaleky
et al., 2005a; Fatemi, 2005; Carulli et al., 2013a; Dick et al., 2013; Vo
et al., 2013b). In particular, Reelin has been extensively investigated
for its role in brain development, synaptic regulation during adulthood
and involvement in several brain disorders, including SZ and bipolar
disorder; although some of these aspects will be mentioned in this
review, we refer to comprehensive publications by other groups for
details (Curran and D'Arcangelo, 1998; Impagnatiello et al., 1998;
Pesold et al., 1999; Guidotti et al., 2000, 2011; Costa et al., 2001;
Fatemi, 2001; Abdolmaleky et al., 2005a; Chen et al., 2005; Sinagra
et al., 2005; Akbarian and Huang, 2006; Dityatev et al., 2006; Eastwood
and Harrison, 2006; Campo et al., 2009; Frotscher et al., 2009;
Frotscher, 2010; Barros et al., 2011; Franco and Muller, 2011; Hondathe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. PNNs in the human amygdala. Photomicrographs of PNNs labeled using the CS-6
antibody 3B3 (A), and the lectin WFA (B; counterstained with Nissl cresyl violet) in the
lateral nucleus of the normal human amygdala. Scale bar = 50 μm.
19S. Berretta et al. / Schizophrenia Research 167 (2015) 18–27et al., 2011; Lakatosova and Ostatnikova, 2012; Flashner et al., 2013;
Folsom and Fatemi, 2013; Stranahan et al., 2013).
2. Perineuronal nets: composition and association with distinct
neuronal populations
The brain ECM surrounds all cells, occupying approximately a
volume fraction of 20% of the normal adult brain (Chvatal et al., 1999;
Zuber et al., 2005; Thorne and Nicholson, 2006; Sykova and Nicholson,
2008). In addition to a loosely organized molecular lattice, the ECM
forms highly structured aggregates, among which PNNs (Fig. 1) are the
most extensively investigated. Their components include chondroitin
sulfate proteoglycans (CSPGs), hyaluronan, tenascin-R, link proteins,
Reelin and semaphorin 3A (Matthews et al., 2002; Deepa et al., 2006;
Carulli et al., 2013b; Dick et al., 2013; Vo et al., 2013a). CSPGs, the
organizers of the ECM, are highly represented in PNNs, with aggrecan,
neurocan, brevican, versican and phosphacan among themost abundant
(Yamaguchi, 2000; Deepa et al., 2006; Giamanco and Matthews, 2012).
These macromolecules consist of core proteins with varying numbers
of chondroitin sulfate (CS) glycosaminoglycan (GAG) chains (Fig. 2).Fig. 2.CSPG structure and cleavage sites. Schematic diagramdepicting the structure of CSPGs, ag
distinct domains (e.g. G1, G2). Attached to the protein core are numerous chondroitin sulfate
consists of repeated pairs of glucuronic acid (GlcA) and N-acetyl-galactosamine (GalNAc). Th
non-reducing terminal end saturated CS disaccharide consisting of glucuronic acid N-acetyl-gal
WFA detects N-actetyl-D-galactosamine on the terminal ends of CS chains, with a preference for
cleaved by severalmetalloproteases, including ADAMTS (triangles) andMMPs (squares) on var
2000; Porter et al., 2005).The number and length of GAG chains, their sulfation patterns (e.g. CS-
6, CS-4; see Fig. 2) and the position of sulfated residueswithin the chains
are key factors in determining their functions, yielding enormous struc-
tural and functional diversity to these molecules (Wang et al., 2008;
Maeda, 2010; Karus et al., 2012; Miyata et al., 2012).
The contribution of such diversity to PNN composition has been, to
some extent, investigated using antibodies raised against core proteins
and speciﬁc sulfation patterns (Bertolotto et al., 1996; Ojima et al.,
1998; Hagihara et al., 1999; Haunso et al., 1999; Matthews et al., 2002;
Yin et al., 2006; Hayashi et al., 2007; Saitoh et al., 2008; Nakamura
et al., 2009; Caterson, 2012; Miyata et al., 2012; Madinier et al., 2014;
Racz et al., 2014), as well as lectins such asWisteria ﬂoribunda agglutinin
(WFA). WFA, perhaps the most widely used in studies of PNNs, binds
speciﬁcally to N-acetyl-D-galactosamine on the terminal end of CS
chains, with a preference for beta glycosidic linkage (Kurokawa et al.,
1976; Young and Williams, 1985). The speciﬁcity of WFA as a marker
for CSPGs is supported by extensive literature, although the speciﬁc
CSPGs and/or sulfation patterns detected by WFA are not currently
known (Hartig et al., 1994; Dityatev et al., 2007; Galtrey and Fawcett,
2007; Pantazopoulos et al., 2010). Immunolabeling using antibodies
against CSPG protein cores or sulfation patterns shows that PNNs are
heterogeneous in composition, with only a subgroup labeled by WFA.
For instance, PNNs containing brevican are broadly distributed across
the brain in regions where few WFA-labeled PNNs are located (Ajmo
et al., 2008). In the human amygdala, we recently investigated PNNs
containing aggrecan, one of the main CSPGs in the brain, or a speciﬁc
CS-6 pattern, detectable with antibody 3B3 (Fig. 2) (Caterson, 2012;
Pantazopolous et al., 2014). Our results show that only approximately
54% of aggrecan-labeled PNNs were co-labeled withWFA. PNNs labeled
with the CS-6 sulfation antibody 3B3 were substantially more numer-
ous, and displayed a broader distribution in the human amygdala with
respect to WFA-labeled PNNs. In the lateral nucleus, 49% of 3B3-IR
PNNs are co-labeled with WFA; this percentage decreases drastically
in the other amygdala nuclei where the large majority of PNNs were
3B3-positive but WFA-negative. Like WFA-labeled PNNs, 3B3-labeled
PNNs show clear interneuron-like morphology, suggesting that a large
population of interneurons in the amygdala is associated with 3B3-
labeled PNNs (see also below). Furthermore, PNNs containing versicangrecan in this speciﬁc example. CSPGs are composed by a protein core protein that includes
d glycosaminoglycan chains, creating a CS rich region (A). Each glycosaminoglycan chain
is latter can be sulfated in position 6 (CS-6) or 4 (CS-4) (B). The antibody 3B3 detects a
actosamine-6-sulfate (CS-6; in A) (Sorrell et al., 1988; Caterson, 2012), whereas the lectin
beta glycosidic linkage (A) (Kurokawa et al., 1976; Young andWilliams, 1985). CSPGs are
ious sites of the protein core; indicated in A are those known for aggrecan (Nakamura et al.,
20 S. Berretta et al. / Schizophrenia Research 167 (2015) 18–27(v0/v1 isoform)were detected selectively in the central nucleus (Fig. 3),
but not in other amygdala nuclei, and represented a clearly distinct
population with respect to those containing WFA (unpublished
observations).
The questions of which neuronal populations bear PNNs and
whether the molecular composition of PNNs is neuron-speciﬁc are
critical to the understanding of their functional role, and the implica-
tions of their pathology in several brain disorders. Several studies in
rodent, human and non-human primates have shown that a large pop-
ulation of WFA-labeled PNNs ensheaths fast-ﬁring inhibitory interneu-
rons expressing the calcium binding protein parvalbumin (PVB) and
Kv3.1b, a subunit of voltage gated potassium channels typically
expressed in fast-ﬁring neurons (Brauer et al., 1993; Hartig et al.,
1995; Morris and Henderson, 2000; Pantazopoulos et al., 2006). More
recent evidence indicates that WFA-labeled PNNs are associated with
more heterogeneous neuronal phenotypes than previously thought,
including several subgroups of interneurons, a small subset of cortico-
cortical pyramidal cells, spinal cord motor neurons and cerebellum
Purkinje cells (Bruckner et al., 1993; Seeger et al., 1994; Brauer et al.,
1995; Hartig et al., 1995; Wegner et al., 2003; Pantazopoulos et al.,
2006; Ajmo et al., 2008; Gati and Lendvai, 2013). Among these,
GABAergic neurons undoubtedly represent one of the largest popula-
tions in several brain regions, including several cortical areas, striatum,
hippocampus, inferior colliculus, septum and amygdala (Hartig et al.,
1994; Seeger et al., 1996; Pantazopoulos et al., 2006; Lee et al., 2012;
Shah and Lodge, 2013; Foster et al., 2014). As an example, in the amyg-
dala of rhesus monkey, the overwhelming majority of WFA-positive
PNNs ensheath neurons expressing glutamic acid decarboxylase
(GAD), a typical marker for GABAergic neurons, with many of these
neurons also expressing PVB and/or calbindin (Hartig et al., 1995).
In the human amygdala, 68% of WFA-labeled PNNs envelop PVB-
positive neurons, a small percentage of which also express calbindin
(Pantazopoulos et al., 2006). This result conﬁrms the association ofFig. 3. PNN numbers in the central nucleus of the amygdala: region speciﬁcity of PNN abnorm
against the v0/v1 isoform of the CSPG versican were exclusively found in the central nucleu
bars = 50 μm. (B) Numbers of PNN containing versican v0/v1 in the central nucleus were no
PNNs were not altered in this nucleus in either disorder. Black circles indicate values for each sWFA-labeled PNNs with PVB-positive neurons, yet indicates that
about a third of these PNNs ensheath other neuronal populations.
Among these are interneurons expressing somatostatin (Fig. 4;
unpublished data), a particularly interesting neuronal population in
light of their expression of the voltage-gated potassium channel subunit
Kv3, which may confer them high frequency ﬁring properties, and
their involvement in psychiatric disorders including schizophrenia
(McDonald and Mascagni, 2006; Volk et al., 2012; Lin and Sibille,
2013; Fung et al., 2014; Volk and Lewis, 2014).
3. Perineuronal net abnormalities in schizophrenia
Our group has shown marked decreases of PNNs in several brain
regions of subjects diagnosed with SZ (Pantazopoulos et al., 2010;
Mauney et al., 2013; Pantazopolous et al., 2014). Lower numbers of
WFA-labeled PNNs were detected in the amygdala, entorhinal and pre-
frontal cortex (Pantazopoulos et al., 2010; Mauney et al., 2013). Within
each brain structure examined, WFA-labeled PNN reductions were
selective for distinct subregions, i.e. the lateral nucleus of the amygdala,
superﬁcial layers of the entorhinal cortex and layers III and V of the
prefrontal cortex. The distribution of these changes matches closely
not only the normal distribution of WFA-labeled PNNs, but also that of
GABAergic interneurons expressing PVB (Pantazopoulos et al., 2010).
Notably, numbers of these neurons were normal in the amygdala and
entorhinal cortex, and densities of WFA-labeled PNNs were unchanged
in the central nucleus of the amygdala and visual cortex of subjects with
SZ (Pantazopoulos et al., 2010;Mauney et al., 2013) (Fig. 3, unpublished
data). Together, these ﬁndings suggest that reductions of WFA-labeled
PNNs in SZ do not simply reﬂect loss of PVB-expressing neurons, and
impact selective populations of these neurons in a region-selective
manner.
We recently tested the hypothesis that PNN decreases in SZ may
be broader than those detected with WFA, affecting several PNNalities in SZ. (A) In the normal human amygdala, PNNs immunolabeled with an antibody
s (A). Inset in A shows numerous versican-immunolabeled PNNs in this nucleus. Scale
rmal in subjects with (SZ) or bipolar disorder (BD). Similarly, numbers of WFA-labeled
ubject, black lines indicate 95% conﬁdence intervals (unpublished data).
Fig. 4. Neurons expressing somatostatin are ensheathed by PNNs. Dual antigen immunoﬂuorescence shows that a subgroup of neurons expressing somatostatin bears PNNs. Similar to
neurons expressing parvalbumin, to a large extent associated with PNNs, somatostatin-positive neurons express voltage-gated potassium channel subunit Kv3 and have been shown
to be altered in psychiatric disorders (McDonald and Mascagni, 2006; Volk et al., 2012; Lin and Sibille, 2013; Fung et al., 2014; Volk and Lewis, 2014). Photomicrographs in A–C show a
neuron expressing somatostatin (green) ensheathed by a PNN containing CSPG CS-6 (3B3). In D–F, a neuron expressing somatostatin (red) is ensheathed by a WFA-labeled PNN. Scale
bars = 50 μm.
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major component of at least a subgroup of PNNs, and GAG chains
containing CS-6, using the antibodies cat 301 and 3B3, respectively
(Pantazopolous et al., 2014) (Fig. 2C). Our results show marked reduc-
tions of aggrecan- and CS6-positive PNNs in the amygdala of SZ subjects
(effect size, aggrecan g=−0.82; 3B3 g=−1.71) (Fig. 5). Decreases of
aggrecan-immunoreactive PNNs were selective for the lateral nucleus
of the amygdala, similar to previous observations usingWFA. However,
only one-third (30%) ofWFA-positive PNNs also express aggrecan, rais-
ing the possibility that neuronal populations affected by WFA- and
aggrecan-positive PNN loss only partially overlap. In contrast, decreases
of CS-6 immunoreactive PNNs were detected broadly across several
amygdala nuclei, including the lateral, basal, accessory basal, cortical,
and medial nuclei. These ﬁndings show that PNN abnormalities in SZ
impact several distinct PNN phenotypes and neuronal populations,
many likely to correspond to interneurons. Remarkably, the central
nucleus of the amygdala appears to be spared by these abnormalities
in SZ. Numbers of PNN immunolabeled for CS-6 (Pantazopolous et al.,2014), WFA, and v0/v1 isoforms of the CSPG versican were normal in
this nucleus (Fig. 3; unpublished data).
In summary, our ﬁndings show consistent reductions of PNNs
in subjects with SZ, affecting molecularly distinct PNN subgroups in
several brain regions. These abnormalities are large in magnitude,
robust to confounding factors and shared by several brain regions
involved in SZ (Pantazopoulos et al., 2010; Mauney et al., 2013;
Pantazopolous et al., 2014). Yet, they are restricted in their distribution
to speciﬁc cortical layers and amygdala nuclei, suggesting specialized
mechanisms affecting distinct neuronal populations.4. Functional implications of PNN abnormalities in schizophrenia
What aspects of the pathophysiology of SZ may be related to
PNN abnormalities? Below, we discuss synaptic functions, including
regulation of glutamatergic transmission inGABAergic neurons, plasticity
and learning and protection from oxidative stress as examples.
Fig. 5.Numbers of PNNs containing CS-6 (3B3) are decreased in the amygdala of subjects with SZ. Lowmagniﬁcation photomicrographs showing PNNs containing CS-6 (antibody 3B3) in
the lateral nucleus of the human amygdala. Note the heterogeneous distribution within the dorsal medial and ventral portions of this nucleus, perhaps reﬂecting topographic association
with distinct inputs. In healthy control subjects, 3B3-immunoreactive PNNs are particularly numerous in the lateral nucleus (A). In subjects with SZ, 3B3-immunoreactive PNNs were
sharply decreased (B) (Pantazopolous et al., 2014). Scale bar = 1000 μm.
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Compelling evidence supports a key role of PNNs in the regulation
of synaptic functions (Dityatev and Schachner, 2006; Frischknecht
and Gundelﬁnger, 2012). PNNs form perisynaptic condensations of
organized ECM, which become an integral component of the functional
synaptic complex. The term ‘tetrapartite synapse’ has been proposed for
this complex, adding ECM perisynaptic condensations to the classic
tripartite synapse formed by pre- and post-synaptic neuronal elements
and glial processes surrounding them (John et al., 2006; Dityatev et al.,
2010; Faissner et al., 2010). The role played by PNNs in synaptic regula-
tion has been extensively discussed by other authors (e.g. Gundelﬁnger
et al., 2010; Dityatev andRusakov, 2011; Frischknecht andGundelﬁnger,
2012), and only brieﬂy summarized here. First, perisynaptic ECM com-
ponents bind and sequestrate neurotrophins and transcription factors,
making them available to cell surface receptors and/or allowing them
to penetrate the cell membrane (Celio and Blumcke, 1994; Galtrey and
Fawcett, 2007; Fawcett, 2009; Beurdeley et al., 2012). Second, PNNs
divide the neuronal surface into multiple compartments, which control
the diffusion of neurotransmitter receptors laterally within the plasma
membrane (Fawcett, 2009; Frischknecht et al., 2009). For instance,
during high frequency ﬁring, desensitized synaptic glutamate AMPA
receptors are exchanged for naive ones, which emerge extrasynaptically
and diffuse laterally into the postsynaptic membrane (Heine et al.,
2008). This process, proposed to represent a fundamental mechanism
for the maintenance of synaptic receptor pools, has been shown to be
controlled by PNNs, which restricted the lateral diffusion of AMPA
receptors and thus allow synaptic desensitization (Heine et al., 2008;
Frischknecht et al., 2009; Frischknecht and Gundelﬁnger, 2012). Consis-
tently, PNN enzymatic digestion results in increased excitability of
interneurons (Dityatev et al., 2007). Third, ECM components have
been shown to interact activelywith surfacemolecules tomodify synap-
tic functions (Gundelﬁnger et al., 2010; Frischknecht and Gundelﬁnger,
2012). Notable examples are interactions of ECMmoleculeswith ‘neuro-
nal activity-regulated pentraxin’ (Narp) complexes and integrins,
shown to regulate AMPA and NMDA receptor subunit composition,
synaptic clustering and homeostatic synaptic scaling in GABAergic
neurons (Cingolani et al., 2008; Campo et al., 2009; Chang et al., 2010;
Dityatev et al., 2010; Frischknecht and Gundelﬁnger, 2012). Relevantto the pathophysiology of several psychiatric disorders, Reelin plays a
key role in these latter mechanisms, interacting with integrins to
regulate NMDA receptor subunit composition (Campo et al., 2009).
The considerations above highlight the effects of PNNs on synaptic
functions and support the idea that PNN disruption in SZ may result in
synaptic dysregulation and altered ﬁring properties of PNN-bearing
neurons. As discussed, these are predominantly represented by
GABAergic neurons, including, but not restricted to, those expressing
PVB and somatostatin (Brauer et al., 1993; Bruckner et al., 1993; Hartig
et al., 1995, 2001; Wintergerst et al., 1996; Haunso et al., 1999; Morris
and Henderson, 2000; Adams et al., 2001; Pantazopoulos et al., 2006;
Pantazopoulos et al., unpublished observations, Fig. 4). Thus, PNN
disruption may impact the activity of intrinsic circuitry and consequent
information outﬂow. A recent study in a rodentmodel is consistent with
this possibility. In this study, PNN enzymatic degradation in the ventral
hippocampus resulted in increased activity of pyramidal neurons, postu-
lated to result from disruption of GABAergic neuronal activity following
PNN loss (Shah and Lodge, 2013). The discrepancy between this and
previous ﬁndings of increased ﬁring in vitro (Dityatev et al., 2007) is
potentially explained by preparation and time course differences. We
suggest that a similar disruption of inhibitory activity may occur in
subjects with SZ in brain regions affected by PNN abnormalities, such as
the amygdala, entorhinal cortex and prefrontal cortex (Pantazopoulos
et al., 2010; Mauney et al., 2013; Pantazopolous et al., 2014). Such dis-
ruption may contribute to increased amygdala activity, consistent
with the observation in SZ subjects tonically and during the processing
of emotional stimuli (Taylor et al., 2005; Holt et al., 2006; Rauch et al.,
2010; Suslow et al., 2013). In animal models, increased activity from
the amygdala has been shown to result in decreased GABA neurons in
sector CA2/3 of the hippocampus, thus potentially contributing to
hippocampal abnormalities in this region in SZ (Benes and Berretta,
2000, 2001; Berretta et al., 2004; Heckers and Benes, 2005; Konradi
et al., 2011; Wang et al., 2011). In the prefrontal cortex, PNN degrada-
tion may affect gamma oscillatory activity originating from interneu-
rons expressing parvalbumin (Carter et al., 1998; Manoach et al.,
1999; Lewis and Gonzalez-Burgos, 2008; Spencer, 2008; Kim and
Webster, 2010; Uhlhaas and Singer, 2010; Woo et al., 2010). Further-
more, given the role of PNNs in regulating the trafﬁcking of glutamate
receptors (Sinagra et al., 2005; Frischknecht et al., 2009), it is possible
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expressing neurons reported in the prefrontal cortex of subjectswith SZ
(Bitanihirwe et al., 2009).
4.2. PNN regulation of synaptic plasticity and learning
In themammalian brain, the composition and properties of the ECM
undergo a profound transformation during late postnatal development
(Lander et al., 1997; Fawcett, 2009; Gundelﬁnger et al., 2010). A juvenile
form of ECM, supportive of neurogenesis, cell migration, axonal
outgrowth and synaptogenesis, is substituted by an adult form, which
predominantly restricts plasticity (Bandtlow and Zimmermann, 2000;
Galtrey and Fawcett, 2007; Fawcett, 2009; Faissner et al., 2010). The
implementation of this adult form of ECM coincides with the closure
of critical periods of postnatal development, during which neuronal
circuits are shaped by experience, and culminates with the maturation
of PNNs and PNN-like perisynaptic ECM aggregates (Pizzorusso et al.,
2002; Yin et al., 2006; McRae et al., 2007; Balmer et al., 2009; Gogolla
et al., 2009; Nowicka et al., 2009; Gundelﬁnger et al., 2010; Takesian
and Hensch, 2013; Ye and Miao, 2013; Xue et al., 2014). Relevant to
the pathophysiology of SZ, in human and non-human primates these
events span across adolescence and early adulthood, potentially coin-
ciding with the prodromal period and onset of SZ (Penn, 2001;
Hensch, 2004; Sturman and Moghaddam, 2011). Consistently, in the
human PFC, numbers of PNNs gradually increase from childhood
through early adulthood, consistent with their role in regulating
human prefrontal cortex circuit reﬁnement (Mauney et al., 2013).
PNN gradual maturation around the somata and dendrites stabilizes
successful synapses, restricting plasticity, regulating synaptogenesis
and maintaining mature forms of learning (Bukalo et al., 2001;
Dityatev et al., 2007; Faissner et al., 2010; Gundelﬁnger et al., 2010;
Pyka et al., 2011; McRae and Porter, 2012; Carulli et al., 2013b). In the
visual cortex, where this process has been most extensively studied,
PNN maturation around PVB-expressing neurons closes the critical
period for ocular dominance (Pizzorusso et al., 2002). Similarly, and
particularly relevant to ﬁndings in SZ, PNNmaturation in the amygdala
determines the transition from juvenile to adult forms of emotion-
related plasticity (Gogolla et al., 2009; Xue et al., 2014). Speciﬁcally,
Gogolla and coworkers demonstrated that PNNs in the amygdala are
necessary to protect fear-related memories from full erasure following
extinction (Gogolla et al., 2009). Localized enzymatic CSPG digestion
in adult animals caused a reversal to a juvenile formof fear conditioning,
one that can be fully erased by extinction (Kim and Richardson, 2007;
Gogolla et al., 2009). Notably, this mechanism was shown to depend
on GABAergic transmission, pointing at the interactions between inhib-
itory interneurons and PNNs in plastic mechanisms. Xue et al. used a
drug-related memory paradigm to demonstrate that PNN control over
extinction memory in the amygdala is not limited to fear learning
(Xue et al., 2014). In their experiments, CSPG/PNN degradation in the
amygdala in combination with extinction training resulted in erasure
of drug (cocaine, morphine)-related memories, facilitated the extinc-
tion of drug-seeking behavior and prevented the spontaneous recovery
and drug-induced reinstatement of drug-seeking behavior (Xue et al.,
2014). Together, this evidence suggests that PNN abnormalities in SZ
may profoundly impact emotion processing and plasticity. Consistent
with this possibility, altered fear learning, and related activity of the
PFC and amygdala, has been reported in subjects with SZ (Holt et al.,
2009, 2012).
4.3. Oxidative stress
Emerging evidence shows that PNNs may play a key role in
protecting neurons from oxidative stress, such as it may be caused by
a decrease of glutathione, a key brain antioxidant found to be decreased
in SZ (Gawryluk et al., 2011; Cabungcal et al., 2013; Suttkus et al., 2014).
In particular, PNN components such as aggrecan, tenascin-R, and linkproteins are essential for this protection (Suttkus et al., 2014). However,
PNNs may in turn be vulnerable to oxidative stress, as shown in mice
with a genetic redox dysregulation (Cabungcal et al., 2013). As proposed
by Do and coworkers, the protection afforded to GABAergic neurons by
PNNs might reﬂect a balance between the oxidative burden on these
ECM structures and the capacity of the system to maintain them
(Cabungcal et al., 2013). Further support for the neuroprotective prop-
erties of PNNs comes from postmortem ﬁndings on older subjects,
showing that neurons enveloped by PNNs contain less of the lysosomal
pigment lipofucsin, which accumulates as a consequence of oxidative
processes (Morawski et al., 2004).
5. Potential causes of PNN abnormalities
In subjectswith SZ, decreases of PNNs inmultiple brain regionswere
robust to confounding variables, including exposure to pharmacological
agents, and did not correlate with age at onset of the disease or duration
of illness (Pantazopoulos et al., 2010;Mauney et al., 2013; Pantazopolous
et al., 2014). These observations are consistent with the idea that PNN
abnormalities in SZ may be inherent to this disorder and, perhaps,
present at its onset. Two main mechanisms, not reciprocally exclusive,
may be postulated. First, PNNs may fail to mature, or form correctly,
during late postnatal development, coinciding with the prodromal
period and age of onset of SZ. Second, during adulthood, PNNs may
undergo degradation, and/or lack stability, as a consequence of dysreg-
ulation of ECM remodeling processes. Our ﬁndings, together with
recent ﬁndings from genetic studies showing that several vulnerability
genes for SZ encode PNN components and enzymes involved in ECM
remodeling, support these hypotheses (Buxbaum et al., 2008;
Rybakowski et al., 2009; Cichon et al., 2011; Dow et al., 2011;
Groszewska et al., 2011; Ripke et al., 2011, 2013; Ripke and
Schizophrenia Working Group of the Psychiatric Genomics, 2014).
5.1. Decreased CSPG availability may contribute to PNN decreases in SZ
Recent ﬁndings from our group show that decreases of PNNs in the
amygdala of subjects with SZ are accompanied by marked reductions
of glial cells expressing aggrecan and CS-6 sulfation (Pantazopoulos et
al., in press). Glial cells are a main source of chondroitin sulfate proteo-
glycans (abbreviated here as CSPGs), and have been shown to critically
contribute to the formation andmaintenance of PNNs (John et al., 2006;
Faissner et al., 2010; Klausmeyer et al., 2011; Wiese et al., 2012). Thus,
these ﬁndings raise the possibility that decreased CSPG synthesis in
glial cells may contribute PNN reductions in SZ. Speculatively, altered
expression of transforming growth factor, and other growth factors
known to powerfully regulate astroglial CSPG synthesis, may play a
role in this mechanism (Smith and Strunz, 2005; Benes et al., 2007;
Markota et al., 2013). In addition, recently reported genetic vulnerabil-
ities for CSPG genes, including PTPRZ1 and neurocan (Buxbaum et al.,
2008; Muhleisen et al., 2012; Ripke and Schizophrenia Working Group
of the Psychiatric Genomics, 2014), may contribute to decrease CSPG
synthesis in SZ. These considerations suggest that reduced availability
of CSPGs, perhaps in part due to genetic factors, may lead to a failure
to form PNNs during late development, potentially disrupting the mat-
uration of inhibitory neural circuits in SZ.
5.2. Disruption of ECM remodeling may contribute to PNN decreases in SZ
Until recently, mature PNNswere considered to be highly stable over
time, and to permanently restrict neuronal plasticity (e.g. Corvetti and
Rossi, 2005; Galtrey and Fawcett, 2007). Emerging evidence supports
the intriguing idea that the ECM, both in its developmental and adult
forms, is constantly remodeled in response to a broad variety of stimuli,
which in adulthood include learning and memory, stress, and immune
system activation (Frischknecht and Gundelﬁnger, 2012). The main
agents of this remodeling process are three families of metalloproteases
24 S. Berretta et al. / Schizophrenia Research 167 (2015) 18–27collectively known as metzincin family, i.e. ‘matrix metalloproteases’
(MMPs), ‘a disintegrin and matrix metalloproteases’ (ADAMS), and
‘ADAMS with a thrombospondin domain’ (ADAMTS), which cleave
ECM molecules, including those that compose PNNs (Fig. 2) (Muir
et al., 2002; Medina-Flores et al., 2004; Abdolmaleky et al., 2005b;
Hobohm et al., 2005; Rivera et al., 2010). For instance, ADAMTSs
are known to cleave multiple PNN components including the CSPGs
aggrecan, brevican, neurocan, versican, and phosphacan (Fig. 2)
(Porter et al., 2005; Tauchi et al., 2012). Notably, metalloproteases play
a key role in synaptic plasticity and memory, creating windows of
opportunity for learning by temporarily releasing neurons from the
ECM clamping effects on plasticity and increasing synaptogenesis
(Wright and Harding, 2009; Rivera et al., 2010; Frischknecht and
Gundelﬁnger, 2012; Van Hove et al., 2012). For instance, expression of
MMP9 was shown to increase in the amygdala, prefrontal cortex, and
hippocampus during contextual fear learning, while pharmacological
disruption of MMP activity results in disruption of reconsolidation
of fear memory (Brown et al., 2009; Ganguly et al., 2013). Similar
disruption of MMP3 and MMP9 activity in the hippocampus results in
disruption of spatial memory and avoidance learning (Nagy et al.,
2007; Wright et al., 2007). Notably, altered expression of MMPs and
ADAMTS was found to be associated with PNN reduction (Gray et al.,
2008).
We suggest that altered expression of members of the metzincin
family of metalloproteases may contribute to a disruption of PNNs in
SZ. Altered metalloproteases expression, during development and/or
adulthood, would result in dysregulation of ECM remodeling with
consequent failure of PNN maturation and impaired PNN stability.
Consistent with this hypothesis, a recent gene expression proﬁling
study of the superior temporal gyrus in subjects with SZ showed altered
mRNA expression of MMPs and ADAMTSs, includingMMP16 (Pietersen
et al., 2014). At least two, potentially linked, factors may lead to a
disruption of metalloprotease expression. First, converging results
from several recent genetic association and genome-wide association
studies indicate that genes encoding for a number of metzincin
metalloproteases may represent vulnerability factors for SZ. These
include ADAMTSL3, ADAMTS12, ADAMTS-16, ADAM22, and MMP16
(Dow et al., 2011; Ripke et al., 2011; Bespalova et al., 2012; McGrath
et al., 2013; Ripke and Schizophrenia Working Group of the Psychiatric
Genomics, 2014). Thus, expression of several metalloproteases may be
altered in subjects with SZ as a result of genetic predisposition. Second,
PNN integrity and expression of metalloproteases are markedly affected
by stress and immune responses (Medina-Flores et al., 2004; Franklin
et al., 2008; Gray et al., 2008; Fillman et al., 2014). These responses
have been linked to the pathogenesis of SZ, with a very recent study
pointing to a genetic contribution to immune factor involvement
(Arion et al., 2007; Saetre et al., 2007; Smith et al., 2007; Fillman et al.,
2013; Horvath and Mirnics, 2014; Ripke and Schizophrenia Working
Group of the Psychiatric Genomics, 2014). Thus, interactions between
dysregulated stress response and immune systems in subjects with SZ
may impact the expression ofmetalloproteases, resulting in degradation
of PNNs.
6. Conclusions
PNN abnormalities may represent an important factor in the patho-
physiology of SZ, contributing to a disruption of GABAergic circuits
observed in this disorder. These abnormalitiesmay result from complex
interactions of genetic vulnerabilities of genes encoding for CSPGs,
metalloproteases and immune system molecules with environmental
factors leading to stress and immune system activation, and in turn
impact postnatal neuronal maturation, protection from oxidative stress,
synaptic regulation and plasticity of distinct interneuronal populations,
potentially accounting for molecular and functional anomalies in
intrinsic inhibitory circuits. In turn, these may result in a disruption of
cognitive and emotional processing.Role of funding sources
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